Genetic Analysis appoints Mira Halvorsen Børstad as commercial leader
She joins the Oslo-based microbiome diagnostics company on September 1 to lead international expansion and strategic partnerships across global markets.
See the latest news and media coverage for Genetic Analysis. We track all announcements, press releases, and industry mentions in real time, all in one place.
Microbiome diagnostic technology developer
genetic-analysis.comLast updated
In short: Genetic Analysis expanded its global reach through new diagnostic launches in Australia and the U.S. while advancing its patent portfolio.
She joins the Oslo-based microbiome diagnostics company on September 1 to lead international expansion and strategic partnerships across global markets.
The meeting on 20 May 2026 in Oslo approved 2025 accounts, elected board members, authorized share capital increases and share buy-backs, and extended the share option program.
The USPTO grants patent no. 12,596,121 for a method assessing IBS patient response to low-FODMAP diet or FMT via gut microbiota analysis. It strengthens their IP portfolio.
The meeting is scheduled for 20 May 2026 in Oslo. Agenda includes approval of 2025 accounts, board elections, remuneration, and authorizations for share capital increases and option programs.
Novogenia AG (ticker symbol: 7V0, formerly Darwin AG), an international healthcare company focused on human genetics and the development of personalized products based on genetic...
For many dealing with irritable bowel syndrome, they're left with more questions than answers. It's...
Some shark species might belong to their own distinct lineage, which is separate from all other sharks, rays and skates, according to a new study...
Track Genetic Analysis and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.